30 Day Trial

ORTHOWORLD » Other Articles of Interest

Headcount Reductions, New Appointments at Biologics and Spine Companies

Alphatec Spine announced a workforce reduction of ~20%, part of its plan to reduce operating expenses by $20 million following sale of its international business to Globus Medical. At the end of 2015, Alphatec employed approximately 430 people worldwide.

Moving forward, Alphatec is focused on U.S. expansion of Arsenal™ Degenerative and Deformity systems, the Battalion™ Universal Interbody System and launches of Battalion Lateral and XYcor® Expandable Spinal Spacer systems (the latter of which received FDA 510(k) market clearance in August 2016).

Amedica has reduced its workforce by ~38% in a move to realize savings of ~$2.0 million in cash operating expenses, on an annualized basis. The company will continue its focus on adding new surgeons, territories and distributors. In March 2016, the company employed 56 people.

Carmell Therapeutics has added members to its senior management team in support of U.S. FDA clearance for REPAIR™ Putty, a plasma-based bioactive product designed to accelerate bone healing. New hires there include Donna Godward, Chief Quality Officer; Stephanie Kladakis, Ph.D., Vice President of R&D and Janet Vargo, Ph.D., Vice President of Clinical Sciences.

Xtant Medical has selected Carl O’Connell as its President, bringing perspective from a range of responsibilities within a variety of medical device segments including spine, extremities and orthobiologics.

Sources: Company press releases, filings with the U.S. Securities and Exchange Commission

0 COMMENTS

Name
Comment